Repaglinide in type 2 diabetes: a 24-week, fixed-dose efficacy and safety study (Q41713661)
Jump to navigation
Jump to search
scientific article published on January 2000
Language | Label | Description | Also known as |
---|---|---|---|
English | Repaglinide in type 2 diabetes: a 24-week, fixed-dose efficacy and safety study |
scientific article published on January 2000 |
Statements
1 reference
Repaglinide in type 2 diabetes: a 24-week, fixed-dose efficacy and safety study (English)
1 reference
Jovanovic L
1 reference
Dailey G 3rd
1 reference
Huang WC
1 reference
Strange P
1 reference
Goldstein BJ
1 reference
1 January 2000
1 reference
1 reference
40
1 reference
1
1 reference
49-57
1 reference
Identifiers
1 reference
1 reference